Combination Therapy with Thalidomide Plus Dexamethasone (THAL/DEX) for Newly Diagnosed Myeloma (MM)

Reviewer: Walter F. Sall, MD
The Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 13 de diciembre del 2001

Translation for this article does not exist


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

Bortezomib Ups Response, Survival in Multiple Myeloma

Jul 25, 2012

Bortezomib induction/maintenance up complete response, progression-free, overall survival rates

Low-Dose Regimen Found to Improve Myeloma Survival

Nov 25, 2015

Lenalidomide plus low-dose dexamethasone better than high-dose dexamethasone

Continuous Therapy Improves Survival in Multiple Myeloma

Aug 31, 2015

Benefit seen in progression-free, overall survival compared with fixed duration of therapy